Jul 10, 01:46 PM

Flagship Pioneering Raises $3.6 Billion with @CEPIvaccines to Advance Bioplatforms and Variant-Resilient Vaccines

Flagship Pioneering has announced a significant capital raise of $3.6 billion, which will be used to advance its innovative bioplatforms and new modalities of medicine. The funding will also support the development of the Octavia™ platform, aimed at creating variant-resilient vaccines to protect humanity against rapidly-evolving viruses, with funding from @CEPIvaccines. The announcement was highlighted in a recent interview with Flagship Founder and CEO Noubar Afeyan, who emphasized the company's commitment to pioneering breakthrough innovations in human health and sustainability.

#Flagship Pioneering #Flagship Founder #Noubar Afeyan

Written with ChatGPT (GPT-4o).